These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Two cases of myeloid disorders and a t(8;12) (q12;p13). Hernández JM; González MB; García JL; Ferro MT; Gutiérrez NC; Marynen P; San Miguel JF Haematologica; 2000 Jan; 85(1):31-4. PubMed ID: 10629588 [TBL] [Abstract][Full Text] [Related]
28. [Refractory anemia with ringed sideroblasts and thrombocytosis: a case report]. Li ZJ; Hua JY; Shi QZ Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):683. PubMed ID: 22339827 [No Abstract] [Full Text] [Related]
29. [A case of a chromsome B4 long arm deletion (B4q-) (author's transl)]. Ferrier S; Freund M Arch Genet (Zur); 1974; 47(1):16-26. PubMed ID: 4469771 [No Abstract] [Full Text] [Related]
30. Risk factor analysis in myelodysplastic syndrome patients with del(20q): prognosis revisited. Liu YC; Ito Y; Hsiao HH; Sashida G; Kodama A; Ohyashiki JH; Ohyashiki K Cancer Genet Cytogenet; 2006 Nov; 171(1):9-16. PubMed ID: 17074585 [TBL] [Abstract][Full Text] [Related]
31. A case of refractory anemia with 17p- syndrome following azathioprine treatment for heart transplantation. Depil S; Lepelley P; Soenen V; Preudhomme C; Lai JL; Broly F; Quesnel B Leukemia; 2004 Apr; 18(4):878. PubMed ID: 14961032 [No Abstract] [Full Text] [Related]
32. Chromosomal abnormalities. Findings in a patient with lymphoma and rheumatoid arthritis treated with intra-articular gold Au 198. Goh K; Jacox RF; Anderson FW Arch Pathol Lab Med; 1980 Sep; 104(9):473-5. PubMed ID: 6893400 [TBL] [Abstract][Full Text] [Related]
33. Terminal deletion of the long arm of chromosome 4. Report of a case of 46, XY, del(4)(q31) and review of 4q- syndrome. Yu CW; Chen H; Baucum RW; Hand AM Ann Genet; 1981; 24(3):158-61. PubMed ID: 6974525 [TBL] [Abstract][Full Text] [Related]
34. Pathology case of the month. Elderly woman with fatigue. The 5q- Syndrome. Wellman G; Veillon DM; Nordberg ML; Young RL; Cotelingam JD J La State Med Soc; 2002; 154(4):175-7. PubMed ID: 12236399 [No Abstract] [Full Text] [Related]
35. Chromosome aberrations including der(6)t(2;6)(p15;p21.3) and der(22)t(3;22)(p21;p11) in the evolution of essential thrombocythemia to myelofibrosis with myeloid metaplasia. Lazarevic V; Andersson C; Wahlin A; Golovleva I Cancer Genet Cytogenet; 2006 Feb; 165(1):87-9. PubMed ID: 16490605 [No Abstract] [Full Text] [Related]
36. Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint. Boultwood J; Fidler C; Lewis S; Kelly S; Sheridan H; Littlewood TJ; Buckle VJ; Wainscoat JS Genomics; 1994 Feb; 19(3):425-32. PubMed ID: 8188284 [TBL] [Abstract][Full Text] [Related]
37. The role of lenalidomide in the management of myelodysplasia with del 5q. Kelaidi C; Eclache V; Fenaux P Br J Haematol; 2008 Feb; 140(3):267-78. PubMed ID: 18217896 [TBL] [Abstract][Full Text] [Related]
38. [The 5q-syndrome as a disorder of the hemopoietic system: a disorder of the bone marrow function characterized by megakaryocytes without a lobulated nucleus and an acquired deletion of the long arm of chromosome 5]. Hupperets P; Hustinx T; Scheres J; Haanen C Ned Tijdschr Geneeskd; 1981 Jul; 125(28):1107-13. PubMed ID: 7254394 [No Abstract] [Full Text] [Related]
39. A retrospective analysis of myelodysplastic syndromes with thrombocytosis: reclassification of the cases by WHO proposals. Cabello AI; Collado R; Ruiz MA; Martínez J; Navarro I; Ferrer R; Sosa AM; Carbonell F Leuk Res; 2005 Apr; 29(4):365-70. PubMed ID: 15725469 [TBL] [Abstract][Full Text] [Related]